BofA reveals 4 biotech top picks for 2024 — giving one 166% upside
The biotech stock with the BofA's biggest upside already has approval for a drug that treats a rare kidney disease affecting up to 150,000 people in the U.S.
Stay updated with breaking news from Greg Harrison. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The biotech stock with the BofA's biggest upside already has approval for a drug that treats a rare kidney disease affecting up to 150,000 people in the U.S.
Noah Cook from Bardsea was crowned as the British under-12 champion, with Theo Zaboklicki finishing as runner-up.
The Union County Clerk's Office on Wednesday provided a comprehensive list of local candidates for office after leaving several who filed to run in 2024 out on Tuesday.
BioXcel Therapeutics, Inc. (NASDAQ:BTAI) Q3 2023 Earnings Call Transcript November 14, 2023 BioXcel Therapeutics, Inc. misses on earnings expectations. Reported EPS is $-1.72 EPS, expectations were $-1.29. Operator: Good morning, and welcome to the BioXcel Therapeutics Conference Call, which will cover its alignment with the FDA on its TRANQUILITY program, provide an update on strategic […]
The candidate filing period for next year's elections closed at noon on Tuesday, and 38 people signed up to run for various local offices.